Versigent
VGNT | NYSE
$40.96
-$0.10 (-0.24%)
At close: Nov 2, 2026, 3:59 PM ET
$41.43
+$0.37 (+0.90%)
Pre-market:
Nov 2, 2026, 8:37 AM ET
Fiscal Quarter Period Ending | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q4 2024 Dec 31, 2024 |
|---|---|---|---|---|---|
Revenue | 2.44B | 2.21B | 2.3B | 2.29B | 2.13B |
Cost of Revenue | 2.12B | 1.97B | 2.03B | 1.99B | 1.86B |
Gross Profit | 321M | 243M | 270M | 296M | 269M |
Operating Income | 199M | 146M | 164M | 192M | 166M |
Interest Income | n/a | 3M | 1M | n/a | 1M |
Pretax Income | 157M | 72M | 115M | 162M | 142M |
Net Income | 118M | 78M | 217M | 105M | 127M |
Selling & General & Admin | 100M | 97M | 106M | 104M | 103M |
Research & Development | n/a | n/a | n/a | n/a | n/a |
Other Expenses | 22M | n/a | n/a | n/a | n/a |
Operating Expenses | 122M | 97M | 106M | 104M | 103M |
Interest Expense | 36M | 5M | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 2.25B | 2.07B | 2.14B | 2.09B | 1.96B |
Income Tax Expense | 46M | -9M | -110M | 53M | 8M |
Shares Outstanding (Basic) | 70.9M | 70.89M | 71.05M | 71.05M | 71.05M |
Shares Outstanding (Diluted) | 71.88M | 70.89M | 71.05M | 71.05M | 71.05M |
EPS (Basic) | 1.66 | 1.10 | 3.05 | 1.48 | 1.79 |
EPS (Diluted) | 1.64 | 1.10 | 3.05 | 1.48 | 1.79 |
EBITDA | 305M | 207M | 225M | 296M | 218M |
EBIT | 193M | 146M | 164M | 241M | 166M |
Depreciation & Amortization | 112M | 61M | 61M | 55M | 52M |
Add to Watchlist
Select watchlists to add or remove VGNT